OPTION AGREEMENT between SCHERING CORPORATION and VIROPHARMA INCORPORATEDOption Agreement • March 19th, 2004 • Viropharma Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 19th, 2004 Company Industry Jurisdiction
EXCHANGE AGREEMENTExchange Agreement • March 19th, 2004 • Viropharma Inc • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 19th, 2004 Company Industry JurisdictionTHIS EXCHANGE AGREEMENT (this “Agreement”), dated as of October 2, 2003 (the “Effective Date”), is made by and between Everspring Master Fund Ltd. (“Everspring”) and ViroPharma Incorporated (the “Company”).
ContractFirst Amended and Restated Agreement • March 19th, 2004 • Viropharma Inc • Pharmaceutical preparations
Contract Type FiledMarch 19th, 2004 Company IndustryPortions of this exhibit were omitted and filed separately with the Secretary of the Commission pursuant to an application for confidential treatment filed with the Commission pursuant to Rule 24b-2 under the Securities Exchange Act of 1934. Such portions are marked by a series of asterisks.
SECOND AMENDED AND RESTATED SEVERANCE AGREEMENTSeverance Agreement • March 19th, 2004 • Viropharma Inc • Pharmaceutical preparations • Pennsylvania
Contract Type FiledMarch 19th, 2004 Company Industry JurisdictionTHIS AMENDED AND RESTATED AGREEMENT dated as of September 1, 2003 is made by and between ViroPharma Incorporated (the “Company”), and Claude Nash (the “Employee”).